Quick Comparison
| Sunifiram | Uridine | |
|---|---|---|
| Half-Life | Estimated 1-2 hours (limited data) | 2-5 hours |
| Typical Dosage | Standard: 4-8 mg sublingually. Active doses are very small — do NOT dose by weight equivalence with piracetam. Start at 4 mg. Do not use daily due to lack of long-term data. Sublingual preferred for consistent absorption. | Standard: 150-250 mg Uridine Monophosphate sublingually or orally, twice daily. Best combined with fish oil (DHA) and a choline source for the full 'Mr. Happy Stack' protocol. |
| Administration | Sublingual (preferred) or oral. Very small doses — requires a milligram scale for accurate dosing. | Sublingual or oral. Uridine monophosphate is the preferred form. Triacetyluridine (TAU) is a more bioavailable prodrug. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
Sunifiram
Sunifiram (DM-235) is a positive allosteric modulator of AMPA receptors (GluA1-4 subunits) — an ampakine that slows receptor desensitization and deactivation, enhancing glutamatergic excitatory neurotransmission and calcium influx through the receptor. This calcium influx activates CaMKII (calcium/calmodulin-dependent protein kinase II), which phosphorylates GluA1 at Ser831 and is a key enzyme in long-term potentiation (LTP) and memory consolidation. Sunifiram also activates protein kinase C (PKC) isoforms, which phosphorylate GluA2 and regulate receptor trafficking. It increases acetylcholine release in the prefrontal cortex and hippocampus, likely via presynaptic nicotinic receptor activation or enhanced glutamatergic drive onto cholinergic neurons. Downstream, these mechanisms enhance CREB phosphorylation, Arc expression, and synaptic AMPA receptor insertion — the molecular basis of memory formation.
Uridine
Uridine (as UMP) is phosphorylated to UTP and enters the Kennedy pathway, where it combines with choline via CTP:phosphocholine cytidylyltransferase to form CDP-choline — the rate-limiting step in phosphatidylcholine synthesis. Uridine provides the nucleotide component needed for constructing phosphatidylcholine in neuronal cell membranes and synaptic vesicles. Uridine stimulates neurite outgrowth and synaptogenesis via activation of P2Y receptors and downstream PI3K/Akt signaling. It upregulates dopamine D2 receptor expression in the striatum and enhances dopaminergic neurotransmission. When combined with DHA (from fish oil) and choline, the three compounds synergistically increase synaptic membrane synthesis, dendritic spine density, and dopaminergic signaling — the 'Mr. Happy Stack' mechanism.
Risks & Safety
Sunifiram
Common
Overstimulation, headache, jaw clenching at higher doses.
Serious
No long-term human safety data. Animal studies show a wide therapeutic index.
Rare
Insomnia, anxiety, irritability.
Uridine
Common
Mild gastrointestinal discomfort, diarrhea.
Serious
Very limited long-term human supplementation data.
Rare
Lethargy, vivid dreams, depressive symptoms in some users.
Full Profiles
Sunifiram →
An experimental ampakine compound structurally related to piracetam but estimated to be 1,000x more potent. Sunifiram enhances AMPA receptor function, increases long-term potentiation in the hippocampus, and activates CaMKII and PKC signaling — molecular processes directly involved in memory formation. It has a noticeable acute effect on focus and memory, but very limited human safety data.
Uridine →
A nucleotide base that plays a critical role in brain cell membrane synthesis, synapse formation, and dopamine receptor expression. Part of the well-known 'Mr. Happy Stack' (Uridine + Fish Oil + Choline) that synergistically supports mood and cognitive function. Uridine monophosphate is the preferred supplemental form for brain bioavailability.